RxDoctor Payments Data

David Killeen, DO

Pulmonary Disease · Salem, VANPI 1700821436

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $34,475 of the $47,253 with a category attached, or 73.0%. Mallinckrodt Enterprises LLC accounts for 89.0% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $42,979 and has fallen 98.0% since, to $870 in 2025. Among pulmonary disease clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$47,253in general payments, 2019–2025

Across 77 payments — averaging $613.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Enterprises LLC$42K
  • Mallinckrodt Hospital Products Inc.$2K
  • Olympus Corporation Of The Americas$908
  • Ceribell, Inc.$770
  • Stryker$569
  • Inari Medical, Inc.$194
  • plus $625 from 9 others

What the payments were for

  • Consulting fees$7502%
  • Speaking & faculty fees$34,47573%
  • Travel & lodging$10,58422%
  • Food & beverage$1,4433%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$47,253 in reported general payments places this provider in the 90th percentile of 317 pulmonary disease providers in Virginia.

See all pulmonary disease providers in Virginia

Medicare billing

Part B allowed, 2024
$50,246
Medicare patients
163
Services billed
328

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Salem

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →